Showing results (451-460 of 461) with videos related to

Sort By:
Pageof 47
Clinical Breast Cancer|December 24, 2022
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World ExperienceKhalil Choucair, Seth J Page, Bassam I Mattar, et al.
JMIR Research Protocols|May 26, 2025
ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
Archives of Gynecology and Obstetrics|April 22, 2025
Therapy of early breast cancer: current status and perspectivesNikolas Tauber, Niklas Amann, Dominik Dannehl, et al.
Pediatric Neurosurgery|January 1, 1996
Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology Group StudyM Deutsch, P R Thomas, J Krischer, et al.
JMIR Research Protocols|June 11, 2025
Correction: ENABLE-App-Based Digital Capture and Intervention of Patient-Reported Quality of Life, Adverse Events, and Treatment Satisfaction in Breast Cancer: Protocol for a Randomized Controlled TrialThomas M Deutsch, Léa L Volmer, Manuel Feisst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiationP R Thomas, M Deutsch, J L Kepner, et al.
International Journal of Cancer|October 27, 2025
Fast enrichment and detection of circulating tumor cells from large volumes of whole blood of breast cancer patients utilizing a functionalized bioaffinity CTC filtration membraneLeonie F Ott, Laura Keller, Nathan Bentley, et al.
Marine Drugs|January 20, 2023
Limited Metabolomic Overlap between Commensal Bacteria and Marine Sponge Holobionts Revealed by Large Scale Culturing and Mass Spectrometry-Based Metabolomics: An Undergraduate Laboratory Pedagogical Effort at Georgia TechJessica M Deutsch, Madison O Green, Priyanka Akavaram, et al.
Breast Cancer Research and Treatment|April 2, 2026
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trialManuel Hörner, Lara M Tretschock, Nelson John, et al.
NPJ Breast Cancer|April 11, 2026
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registryManuel Hörner, Andreas Hartkopf, Nelson John, et al.
Pageof 47